A Mount Sinai-led team of researchers has enhanced an artificial intelligence (AI)-powered algorithm to analyze video ...

On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Colorectal cancer (CRC) is a global health concern, and despite advances in radiotherapy, endogenous radioresistance in CRC ...

The UK's self-regulated system for disclosing payments from drug companies to healthcare professionals and organizations is ...

A study comparing oral glucose-lowering agents to insulin for gestational diabetes found no non-inferiority in preventing ...

The impact of maternal antidepressant and anti-inflammatory use on breast milk composition shows reduced protein and fat ...

Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended ...

Beneficial gut microbes and the body work together to fine-tune fat metabolism and cholesterol levels, according to a new ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland School of Medicine provided an extensive analysis on the second patient in ...